Digital Medical Technologies, dba AdhereTech, creates bottles that measure pills or liquid in real-time, wirelessly send this HIPAA-compliant data into the cloud, and remind patients to take their medication via automated phone call or text message.
AdhereTech's Products & Differentiators
AdhereTech Smart Adherence System
The AdhereTech Smart Adherence System is proven to improve adherence and extend duration on therapy by empowering patients and healthcare teams to achieve medication success throughout the patient journey: The Smart Bottle gently informs the patient to their dose time and prompts them only if they have not taken their medication. Real-time, 2-way connection with patients via text and phone communications provides a feedback loop that supports patients from day one. Actionable data supports rapid response from live support specialists and alerts to pharmacy care teams ensure patients receive timely support to overcome challenges and stay on therapy.
Expert Collections containing AdhereTech
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
AdhereTech is included in 3 Expert Collections, including Conference Exhibitors.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
AdhereTech has filed 5 patents.
Computer memory, Capacitors, Remote desktop, Computer data storage, Medical terminology
Computer memory, Capacitors, Remote desktop, Computer data storage, Medical terminology
Latest AdhereTech News
Sep 6, 2023
Brings significant experience in successfully commercializing novel products in both the pharmaceutical and technology industries Will drive company as it grows and brings its technology to market NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- AdhereTech, Inc., a leading digital healthcare company focused on building cloud-based software and devices that seamlessly connect patients to care, today announces that Innes Meldrum has been appointed President and Chief Executive Officer. He is succeeding Chris O'Brien, who will support Innes in the next phase of the Company’s growth. Innes Meldrum has nearly 30 years of global experience in the pharmaceutical and technology industries. He most recently served as Chief Executive Officer of Reset Pharmaceuticals. Prior to this, he served as Senior Vice President and Chief Commercial Officer for Otsuka Pharmaceuticals North America. In this role, he was responsible for all commercial activities, including Otsuka’s psychiatry business and the commercialization of CNS drugs such as Abilify Maintena®. Before this, he served as Commercial Vice President at Orexo, focused on addiction medicine, and prior to this spent 11 years in commercial roles of increasing responsibility at Novartis in the US, as well as within the global organization based in Switzerland. “We are delighted to have Innes join AdhereTech,” said Neale Trangucci, Chair of the Board. “He is a highly experienced international life sciences and technology executive who has led cross-functional development and commercialization teams, having successfully launched and marketed both medicines and technologies in his career. His proven track record and ability to develop top-notch teams will be vital for the Company as we prepare for the next phase of growth. I warmly welcome Innes and look forward to working with him. I also would like to thank Chris O'Brien for his leadership and am pleased he will advise Innes and the Company going forward.” Daniel Raynor, Managing Partner and Co-founder of Argentum, AdhereTech’s main investor, said, “We believe Innes’ successful track record in both the pharma and technology spaces of developing and commercializing innovative, patient-focused solutions will lend itself well to establishing AdhereTech as the market leader in providing technologies to address medication management and adherence challenges.” Innes Meldrum, President and Chief Executive Officer, commented, “I am excited to join AdhereTech as the Company grows its footprint and impact and look forward to working with the team to accelerate the positive patient impact of AdhereTech’s technologies.” In addition to causing unnecessary health complications for patients, nonadherence to medication regimens costs the pharmaceutical industry hundreds of billions of dollarsi per year. About AdhereTech, Inc. AdhereTech is a New York-based digital health company and the leading provider and pioneer of smart devices that connect patients to care via real-time interventions. AdhereTech partners with pharmaceutical manufacturers, specialty pharmacies and healthcare teams with the mission of using technology informed by insights into human behavior to improve health outcomes. The Company provides commercialized digital solutions to measure and manage medication adherence in a variety of settings, including academics, clinical trials, and commercially prescribed treatments. It develops and produces treatment management solutions utilizing smart devices with integrated cellular technology that, seamlessly, connects patients in real time to confirm when patients take their medication and provides two-way communications to ensure dosing regimens are followed and reports and escalates the reasons for missed doses. Its Aidia System™ is a proven, integrated technology-based adherence solution that empowers patients and healthcare teams to achieve optimal medication success. For more information, please visit us at www.adheretech.com . You can also follow us on LinkedIn and Twitter , @AdhereTech. Abilify Maintena® is a registered trademark of Otsuka Pharmaceutical Co., Ltd. For further information please contact: AdhereTech, Inc.
AdhereTech Frequently Asked Questions (FAQ)
When was AdhereTech founded?
AdhereTech was founded in 2011.
Where is AdhereTech's headquarters?
AdhereTech's headquarters is located at 11 Broadway, New York.
What is AdhereTech's latest funding round?
AdhereTech's latest funding round is Private Equity.
How much did AdhereTech raise?
AdhereTech raised a total of $2.07M.
Who are the investors of AdhereTech?
Investors of AdhereTech include Argentum Group and Blueprint Health.
Who are AdhereTech's competitors?
Competitors of AdhereTech include MediSafe and 7 more.
What products does AdhereTech offer?
AdhereTech's products include AdhereTech Smart Adherence System.
Compare AdhereTech to Competitors
AiCure operates as an artificial intelligence (AI) and advanced data analytics company targeting the healthcare industry. It uses artificial intelligence (AI) to understand people's responses regarding clinical trials and patient care. The company was founded in 2010 and is based in New York, New York.
MediSafe develops a medication engagement platform. The platform helps people integrate healthier behavior into their daily lives with a cloud-synced mobile medication management system. It offers solutions, data insights, research, webinars, case studies, and more. The company is founded in 2012 and is based in Needham, Massachusetts.
Redi Health develops a platform to empower patients to take control of and contribute to their health journey. It offers features such as two-way messaging, provider interfaces, call scheduling capabilities, and engagement dashboards. Redi Health was formerly known as BG Tech. It was founded in 2021 and is based in Columbus, Ohio.
Perx Health develops a user-first smartphone application to motivate people to take medication as prescribed. The company's application reminds, educates, and monitors the user's medication regime and also gives users the opportunity to earn rewards every time they stick to the schedule. It was founded in 2016 and is based in Sydney, Australia.
BrightInsight develops a platform for biopharma and medtech-regulated digital health products. The company provides digital health solutions for cardiovascular diseases, diabetes, immunology, oncology, and more. It was formerly known as Flex Digital Health. The company was founded in 2017 and is based in San Jose, California.
Intellihealth operates as a medical technology company. It creates cloud-based clinical decision-making software and a population health management platform for metabolic health helping to improve outcomes and optimize the diagnosis, prescriptive process, and therapy plan to treat obesity. The company was founded in 2018 and is based in San Francisco, California.